Fig. 4From: Whole brain radiation therapy plus focal boost may be a suitable strategy for brain metastases in SCLC patients: a multi-center studyIntracranial progression-free survival analyses according to treatment group in all patients. Whole-brain radiation therapy plus focal radiation boost (WBRT+boost) group experienced a significantly longer intracranial progression-free survival than did whole brain radiation therapy (WBRT) alone (10.8 vs 6.5 months; P = 0.005) or stereotactic radiosurgery (SRS) alone (10.8 vs 7.5 months; P = 0.032)Back to article page